Acute Myocardial Infarction (AMI)
71
20
25
25
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 71 trials
100.0%
+13.4% vs benchmark
15%
11 trials in Phase 3/4
4%
1 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 25 completed trials
Clinical Trials (71)
Using Advanced CT Scans and Blood Markers to Better Understand Heart Damage and Recovery After a Heart Attack
A Study on the Development and Application of a Cardiac Rehabilitation Nursing Intervention Protocol for Patients With First-Episode Acute Myocardial Infarction Following PCI, Based on a Socio-Ecological Theory Model
AI-ECG for Predicting CMR-Defined Myocardial Injury in Acute Myocardial Infarction
Timing of Empagliflozin in Primary PCI: Pre-Reperfusion Versus Post-Reperfusion Versus Placebo in South Asian STEMI Patients
A Clinical Cohort Registry Study on Primary PCI for Acute Myocardial Infarction at Zhongshan Hospital
BRIDGE Trial: Embedding Consumer-grade mHealth Technologies Into Cardiac Rehabilitation
Early Ga-68 FAPI PET/MR After Acute Myocardial Infarction
Artificial Intelligence Scalable Solution for ST Myocardial Infarction
Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock
Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)
Prospective Cohort Study of Aging in Patients With Acute Myocardial Infarction
Use and Costs of P2Y12 Inhibitors After Acute Myocardial Infarction
One-hoUr Troponin Using a High-sensitivity Point-Of-Care Assay in Emergency Primary Care
CRP Apheresis in Infarct-Related Cardiogenic Shock
Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction
Machine Learning for Diagnosis of Occlusive MI in LBBB Patients
Ventricular Arrhythmias in Acute Myocardial Infarction
Dexrazoxane to Protect Against Hemorrhagic STEMI
Early CMR in Acute MI
Acute MI Staging Diagnosis by High-sensitivity Cardiac Troponin-I